- Home
- TWST vs IMOS Comparison
TWST vs IMOS Comparison
Compare TWST & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TWST | IMOS |
|---|---|---|
| Founded | 2013 | 1997 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | TWST | IMOS |
|---|---|---|
| Price | $46.04 | $35.30 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $47.89 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 44.4K |
| Earning Date | 02-02-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 1.75% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | $391,557,000.00 | ★ $748,307,671.00 |
| Revenue This Year | $16.77 | $5.78 |
| Revenue Next Year | $15.06 | $10.84 |
| P/E Ratio | ★ N/A | $165.90 |
| Revenue Growth | ★ 18.59 | N/A |
| 52 Week Low | $23.30 | $12.78 |
| 52 Week High | $54.74 | $45.43 |
Technical Indicators
Market Signals| Indicator | TWST | IMOS |
|---|---|---|
| Relative Strength Index (RSI) | 69.16 | 44.90 |
| Support Level | $39.66 | $33.25 |
| Resistance Level | $43.34 | $42.92 |
| Average True Range (ATR) | 2.50 | 1.36 |
| MACD | 0.16 | -1.00 |
| Stochastic Oscillator | 77.41 | 15.31 |
Price Performance
Historical ComparisonAbout TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.